Market gains concentrated in biggest stocks

MAY 26, 2017

So far this year, 15 stocks have accounted for 50% of the gains in the Standard & Poor's 500. Should you be worried? Not yet. According to preliminary data from S&P, the blue-chip index has gained 8.27% this year, including reinvested dividends. Apple, up 24.5% this year, accounted for 12.8% of the S&P 500's 2017 gain. Currently, the 15 largest S&P 500 stocks are worth more than the 355 smallest members of the index. Market technicians like to see plenty of stocks participating in a rally. As a bull market gets long in the tooth, fewer and fewer stocks join in the fun until, eventually, the number of stocks falling overwhelm those gaining. To market technicians, the rate of participation in a rally is called "breadth," and declining breadth is a warning signal of a downturn. The classic way to measure breadth is the advance-decline line, which tracks the net number of stocks advancing in an index, such as the NYSE composite. A divergence between the advance-decline line and the NYSE composite can be a warning that the rally is falling apart: Typically, the advance-decline line starts to decline a few months before a major top, said Doug Ramsey, chief market strategist for the Leuthold Group. One sign of increased concentration in the stock market: Indexes weighted by market capitalization are leading equal-weighted ones. For example, the Vanguard S&P 500 ETF (VOO) has gained 8.74% this year, including reinvested dividends, and the Guggenheim S&P 500 Equal Weighted ETF (RSP) has gained 6.7%. The concentration of this year's gains in a few stocks is somewhat concerning to market technicians, but has not reached alarming levels yet, "breadth is not as powerful as it was from the run off the lows in February, but that's when you'd expect the strongest breadth," Mr. Ramsey said. "It's not surprising that things would thin out somewhat."

Latest News

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

Investors accuse Netcapital of inflating revenue through sham deals
Investors accuse Netcapital of inflating revenue through sham deals

Sham agreements allegedly padded revenue by 345%.

Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli
Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli

"Most pre-retirees are uncomfortable making key retirement income decisions without an advisor's help," said Chris Bailey of Cerulli.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor